TLR4 and plasma cell myeloma: In particular, activation of TLR4 by lipopolysaccharide (LPS) influences mitochondrial dynamics in myeloma PCs and contributes to bioenergetic changes in PCs resistant to proteasome inhibitors including an increase in mitochondrial mass and an increased reliance on mitochondrial respiration [5,6,7,8].